US Stock MarketDetailed Quotes

CUE Cue Biopharma

Watchlist

1.365
-0.045-3.19%

Close Apr 26 16:00 ET

1.369
+0.004+0.32%

Post 19:28 ET

66.40MMarket Cap-1229P/E (TTM)

Cue Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

340.96%5.49M

1,105.96%1.82M

2,988.24%2.1M

5,215.38%1.38M

-81.30%187K

-91.67%1.25M

-98.17%151K

-97.16%68K

-99.05%26K

-35.61%1M

Operating revenue

340.96%5.49M

1,105.96%1.82M

2,988.24%2.1M

5,215.38%1.38M

-81.30%187K

-91.67%1.25M

-98.17%151K

-97.16%68K

-99.05%26K

-35.61%1M

Cost of revenue

Gross profit

Operating expense

5.00%57.48M

3.06%15.5M

21.80%13.52M

11.40%14.9M

-10.97%13.57M

-6.66%54.75M

-6.88%15.04M

-27.99%11.1M

2.55%13.37M

8.29%15.24M

Selling and administrative expenses

3.16%16.68M

24.43%4.61M

3.32%3.65M

12.35%4.25M

-19.01%4.18M

-6.57%16.17M

-20.29%3.7M

-14.47%3.53M

-11.64%3.78M

21.18%5.16M

-General and administrative expense

3.16%16.68M

24.43%4.61M

3.32%3.65M

12.35%4.25M

-19.01%4.18M

-6.57%16.17M

-20.29%3.7M

-14.47%3.53M

-11.64%3.78M

21.18%5.16M

Research and development costs

5.76%40.8M

-3.93%10.89M

30.42%9.87M

11.03%10.65M

-6.85%9.39M

-6.70%38.58M

-1.47%11.33M

-32.93%7.57M

9.47%9.59M

2.71%10.08M

Operating profit

2.82%-51.99M

8.13%-13.68M

-3.52%-11.42M

-1.27%-13.52M

6.03%-13.38M

-22.40%-53.5M

-88.58%-14.89M

15.26%-11.03M

-29.55%-13.35M

-13.74%-14.24M

Net non-operating interest income expense

558.60%1.42M

45.26%398K

444.74%414K

381.36%332K

1,694.12%271K

368.43%215K

6,929.25%274K

204.00%76K

-591.67%-118K

-230.77%-17K

Non-operating interest income

186.75%2.66M

43.20%905K

250.00%700K

540.91%564K

7,912.50%641K

1,921.87%928K

16,113.44%632K

700.00%200K

266.67%88K

-38.46%8K

Non-operating interest expense

74.61%1.25M

41.62%507K

130.65%286K

12.62%232K

1,380.00%370K

--713K

--358K

--124K

--206K

--25K

Other net income (expense)

-156.68%-157K

277K

19K

258K

Special income (charges)

-156.68%-157K

-926.32%-157K

--0

----

--277K

--19K

--0

--258K

----

-Less:Impairment of capital assets

----

--0

----

--0

---258K

----

-Gain on sale of property,plant,equipment

-156.68%-157K

----

--277K

----

Income before tax

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-21.40%-53.01M

-84.96%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

Income tax

Net income

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-20.04%-53.01M

-74.04%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

Net income continuous Operations

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-20.04%-53.01M

-74.04%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

Minority interest income

Net income attributable to the parent company

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-20.04%-53.01M

-74.04%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

4.30%-50.73M

7.94%-13.43M

-0.46%-11.01M

0.17%-13.19M

8.04%-13.11M

-20.04%-53.01M

-74.04%-14.59M

15.69%-10.96M

-28.49%-13.21M

-13.99%-14.26M

Basic earnings per share

25.50%-1.11

23.68%-0.29

22.58%-0.24

21.62%-0.29

34.09%-0.29

-5.67%-1.49

-52.00%-0.38

24.39%-0.31

-12.12%-0.37

-7.32%-0.44

Diluted earnings per share

25.50%-1.11

23.68%-0.29

22.58%-0.24

21.62%-0.29

34.09%-0.29

-5.67%-1.49

-52.00%-0.38

24.39%-0.31

-12.12%-0.37

-7.32%-0.44

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	340.96%5.49M	1,105.96%1.82M	2,988.24%2.1M	5,215.38%1.38M	-81.30%187K	-91.67%1.25M	-98.17%151K	-97.16%68K	-99.05%26K	-35.61%1M
Operating revenue	340.96%5.49M	1,105.96%1.82M	2,988.24%2.1M	5,215.38%1.38M	-81.30%187K	-91.67%1.25M	-98.17%151K	-97.16%68K	-99.05%26K	-35.61%1M
Cost of revenue
Gross profit
Operating expense	5.00%57.48M	3.06%15.5M	21.80%13.52M	11.40%14.9M	-10.97%13.57M	-6.66%54.75M	-6.88%15.04M	-27.99%11.1M	2.55%13.37M	8.29%15.24M
Selling and administrative expenses	3.16%16.68M	24.43%4.61M	3.32%3.65M	12.35%4.25M	-19.01%4.18M	-6.57%16.17M	-20.29%3.7M	-14.47%3.53M	-11.64%3.78M	21.18%5.16M
-General and administrative expense	3.16%16.68M	24.43%4.61M	3.32%3.65M	12.35%4.25M	-19.01%4.18M	-6.57%16.17M	-20.29%3.7M	-14.47%3.53M	-11.64%3.78M	21.18%5.16M
Research and development costs	5.76%40.8M	-3.93%10.89M	30.42%9.87M	11.03%10.65M	-6.85%9.39M	-6.70%38.58M	-1.47%11.33M	-32.93%7.57M	9.47%9.59M	2.71%10.08M
Operating profit	2.82%-51.99M	8.13%-13.68M	-3.52%-11.42M	-1.27%-13.52M	6.03%-13.38M	-22.40%-53.5M	-88.58%-14.89M	15.26%-11.03M	-29.55%-13.35M	-13.74%-14.24M
Net non-operating interest income expense	558.60%1.42M	45.26%398K	444.74%414K	381.36%332K	1,694.12%271K	368.43%215K	6,929.25%274K	204.00%76K	-591.67%-118K	-230.77%-17K
Non-operating interest income	186.75%2.66M	43.20%905K	250.00%700K	540.91%564K	7,912.50%641K	1,921.87%928K	16,113.44%632K	700.00%200K	266.67%88K	-38.46%8K
Non-operating interest expense	74.61%1.25M	41.62%507K	130.65%286K	12.62%232K	1,380.00%370K	--713K	--358K	--124K	--206K	--25K
Other net income (expense)	-156.68%-157K					277K	19K		258K
Special income (charges)	-156.68%-157K	-926.32%-157K	--0	--0	----	--277K	--19K	--0	--258K	----
-Less:Impairment of capital assets	----	----	--0	--0	----	----	----	--0	---258K	----
-Gain on sale of property,plant,equipment	-156.68%-157K	----	----	----	----	--277K	----	----	----	----
Income before tax	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-21.40%-53.01M	-84.96%-14.59M	15.69%-10.96M	-28.49%-13.21M	-13.99%-14.26M
Income tax
Net income	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-20.04%-53.01M	-74.04%-14.59M	15.69%-10.96M	-28.49%-13.21M	-13.99%-14.26M
Net income continuous Operations	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-20.04%-53.01M	-74.04%-14.59M	15.69%-10.96M	-28.49%-13.21M	-13.99%-14.26M
Minority interest income
Net income attributable to the parent company	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-20.04%-53.01M	-74.04%-14.59M	15.69%-10.96M	-28.49%-13.21M	-13.99%-14.26M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	4.30%-50.73M	7.94%-13.43M	-0.46%-11.01M	0.17%-13.19M	8.04%-13.11M	-20.04%-53.01M	-74.04%-14.59M	15.69%-10.96M	-28.49%-13.21M	-13.99%-14.26M
Basic earnings per share	25.50%-1.11	23.68%-0.29	22.58%-0.24	21.62%-0.29	34.09%-0.29	-5.67%-1.49	-52.00%-0.38	24.39%-0.31	-12.12%-0.37	-7.32%-0.44
Diluted earnings per share	25.50%-1.11	23.68%-0.29	22.58%-0.24	21.62%-0.29	34.09%-0.29	-5.67%-1.49	-52.00%-0.38	24.39%-0.31	-12.12%-0.37	-7.32%-0.44
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall